Whither interferon for myeloma and other hematologic malignancies?
- PMID: 8534004
- DOI: 10.7326/0003-4819-124-2-199601150-00012
Whither interferon for myeloma and other hematologic malignancies?
Comment on
-
Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group.Ann Intern Med. 1996 Jan 15;124(2):212-22. doi: 10.7326/0003-4819-124-2-199601150-00004. Ann Intern Med. 1996. PMID: 8533996 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical